Technical Analysis for CBIO - Catalyst Inc.

Grade Last Price % Change Price Change
grade F 5.66 5.01% 0.27
CBIO closed up 5.01 percent on Monday, August 10, 2020, on 86 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up
Historical CBIO trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Bollinger Band Squeeze Range Contraction 5.01%
BB Squeeze Started Range Contraction 5.01%
1,2,3 Retracement Bearish Bearish Swing Setup 4.81%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 4.81%
MACD Bullish Signal Line Cross Bullish 4.81%
NR7 Range Contraction 4.81%
Inside Day Range Contraction 4.81%
Up 3 Days in a Row Strength 4.81%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Catalyst Biosciences, Inc., a biopharmaceutical company, focuses on discovering and developing novel biopharmaceutical products based on engineered human proteases. The company designs its proteases to promote hemostasis and to prevent inflammation. Its pipeline of protease therapeutics include CB 813d/PF-05280602, an engineered Factor VIIa drug candidate that completed a Phase 1 clinical trial evaluating safety and tolerability, as well as pharmacokinetics, pharmacodynamics, and coagulation activity. The company's pre-clinical development stage drugs comprise CB 2679d/ISU 304, a next-generation Factor IX drug for the treatment of hemophilia B inhibitor patients; and an engineered Factor Xa for hemophilia and the control of bleeding in non-hemophilia patients. It also develops factor C3 for the prevention of renal delayed graft function and the treatment of dry age-related macular degeneration. Catalyst Biosciences, Inc. is headquartered in South San Francisco, California.
Biopharmaceutical Inflammation Molecular Biology Cell Biology Anatomy Macular Degeneration Pharmacokinetics Hemophilia Biopharmaceutical Products Coagulation System Pharmacodynamics Treatment Of Hemophilia Coagulation Dry Age Related Macular Degeneration Factor X

Is CBIO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.94
52 Week Low 3.43
Average Volume 378,878
200-Day Moving Average 5.99
50-Day Moving Average 6.26
20-Day Moving Average 5.56
10-Day Moving Average 5.37
Average True Range 0.35
ADX 31.77
+DI 15.69
-DI 21.48
Chandelier Exit (Long, 3 ATRs ) 5.09
Chandelier Exit (Short, 3 ATRs ) 5.94
Upper Bollinger Band 6.05
Lower Bollinger Band 5.07
Percent B (%b) 0.6
BandWidth 17.63
MACD Line -0.20
MACD Signal Line -0.24
MACD Histogram 0.0437
Fundamentals Value
Market Cap 24.39 Million
Num Shares 4.31 Million
EPS -14.07
Price-to-Earnings (P/E) Ratio -0.40
Price-to-Sales 35.66
Price-to-Book 0.66
PEG Ratio 0.03
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.12
Resistance 3 (R3) 6.08 5.90 6.04
Resistance 2 (R2) 5.90 5.78 5.91 6.02
Resistance 1 (R1) 5.78 5.71 5.84 5.81 5.99
Pivot Point 5.59 5.59 5.62 5.61 5.59
Support 1 (S1) 5.47 5.48 5.53 5.51 5.33
Support 2 (S2) 5.29 5.40 5.30 5.30
Support 3 (S3) 5.17 5.29 5.28
Support 4 (S4) 5.20